serve as training platforms, more researchers who can enter the field of study, a larger and more reliable funding environment, and better scientific tools.
It is noteworthy that the Secretary of Health and Human Services approved an action plan on August 23, 2001, to increase the infrastructure for TSE research (DHHS, 2001). Achieving the laudable goals set forth in that plan will take sustained attention, effort, and funding.
DHHS (U.S. Department of Health and Human Services). 2001. Bovine Spongiform Encephalopathy/Transmissible Spongiform Encephalopathy (BSE/TSE): Action Plan. Washington, D.C.: U.S. Department of Health and Human Services.
European Commission (Research Directorate General, Quality of Life and Management of Living Resources Programme). 2001. Inventory of National Research Activities in Transmissible Spongiform Encephalopathies (TSEs) in Europe. Brussels: European Commission.
Johnson RT. 2002. Summary of NIH Intramural and Extramural TSE Research Efforts. Presentation to the National Prion Research Program Stakeholders Meeting. Alexandria, VA.
Raeber A. 2002. Is BSE a Worldwide Problem? Commercial Diagnostic Testing for TSEs in Europe. Presentation to The IOM Committee on Transmissible Spongiform Encephalopathies: Assessment of Relevant Science, Meeting I. The National Academies, Washington, D.C.
WHO (World Health Organization). 2000. WHO Consultation on Public Health and Animal Transmissible Spongiform Encephalopathies: Epidemiology, Risk and Research Requirements. Geneva: World Health Organization Communicable Disease Surveillance Control and Office International des Epizootics.
WHO. 2001. Working Group on International Reference Materials for Diagnosis and Study of Transmissible Spongiform Encephalopathies (TSEs): Third Meeting. Blood Safety and Clinical Technology. Geneva.